Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsHighmark WV Vyleesi Prior Auth Coverage | OpenPaye…
    Ask Trek AI about this page
    CurrentHighmark West VirginiaPolicy N/A

    Vyleesi (bremelanotide) prior authorization form coverage criteria

    Customize your policy alerts

    Sign up for all Highmark West Virginia policy alerts

    Know when Highmark West Virginia releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document is a prior authorization request form for Vyleesi (bremelanotide) for treatment of hypoactive sexual desire disorder (HSDD) in premenopausal females; it governs information providers must supply to request initial or reauthorization of therapy from Highmark West Virginia.

    Policy Summary
    PayerHighmark West Virginia
    PolicyVyleesi (bremelanotide) prior authorization form coverage criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit completed form with member and provider information, medication details, clinical answers about HSDD and behavioral therapy, and supporting documentation to request authorization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    preauthorizationdocument type
    HSDDtarget diagnosis

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    included
    reauthorization
    requestedmedication details

    Coverage Criteria and Form Requirements

    Form-based coverage considerations

    Coverage consideration requires completion of and answers to the following fields on the form

    Form completion and clinical confirms: Member and provider identifying information completed AND medication details provided (drug name, strength, requested quantity, requested day supply, directions, diagnosis/ICD-10) AND member is premenopausal AND member has a diagnosis of HSDD

    All fields required on the form

    Assessment of contributing factors: Documentation whether HSDD is related to a co-existing medical or psychiatric condition, relationship problems, or the effects of a medication or drug substance

    If related, document on the form

    Behavioral therapy status: Member is a candidate for behavioral therapy OR currently enrolled in behavioral therapy OR has experienced therapeutic failure in behavioral therapy

    Form asks these three items to support need for pharmacotherapy

    Reauthorization evidence: For reauthorization requests: documentation of improved sexual desire from baseline while on Vyleesi

    Yes/No question on form

    Requested Diagnosis and Codes

    Requested Diagnosis CodesICD-10
    Diagnosis/ICD-10Requested field for diagnosis and/or ICD-10 code(s) (no specific codes provided on form)

    Provider Actions, Submission, and Prior Authorization

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required. Complete the medication and clinical information sections confirming premenopausal status and diagnosis, and include all requested medication details and supporting clinical documentation when submitting the request.

    • Complete ALL sections of the form, including member and provider information, medication name, strength, quantity, day supply, directions, and diagnosis/ICD-10 code(s).
    • Confirm whether the member is a premenopausal female and whether the member has a diagnosis of HSDD.
    • If HSDD is present, indicate whether the diagnosis is related to other medical/psychiatric conditions or medications, and complete the behavioral therapy assessment questions (candidate for behavioral therapy, enrollment status, and therapeutic failure).
    • For reauthorization requests, provide information about clinical response (improved sexual desire from baseline while on therapy).
    • Attach prior medication history and any other clinical documentation required to support medical necessity.

    Background

    This prior authorization request form is intended for premenopausal females with hypoactive sexual desire disorder (HSDD) who are being considered for treatment with Vyleesi (bremelanotide). The form collects necessary member and provider identifying information, specific medication details (drug name, strength, requested quantity and day supply, directions, and diagnosis/ICD-10), and targeted clinical information to confirm the member’s eligibility and clinical need for therapy.

    Key clinical questions on the form require confirmation that the member is a premenopausal female and has a diagnosis of HSDD, assessment of whether HSDD is related to co-existing medical/psychiatric conditions, relationship problems, or medication/substance effects, and documentation regarding behavioral therapy (whether the member is a candidate for behavioral therapy, currently enrolled, or has experienced therapeutic failure).

    For reauthorization requests the form specifically asks whether the member is experiencing improved sexual desire from baseline while on Vyleesi, which must be documented to support continuation of therapy. Providers must follow the form instructions for submission (fax to 1-866-240-8123 or mail to the SPECARE address) and complete all required fields to allow coverage consideration.

    Definitions

    HSDD definition and related items
    TermHSDD (hypoactive sexual desire disorder)
    Target populationPremenopausal female members
    Assessment of contributing factorsForm asks whether HSDD is related to co-existing medical/psychiatric conditions, relationship problems, or medication/substance effects
    Behavioral therapy status (most actionable)Form requires documentation whether member is a candidate for behavioral therapy, currently enrolled in behavioral therapy, or has experienced therapeutic failure in behavioral therapy
    Diagnosis confirmationForm asks explicitly whether the member has a diagnosis of HSDD

    Initial Therapy Requirements

    Initial therapy requirements

    Initial authorization requires clinical and medication details

    Initial authorization: Provider must supply member and provider identifying information, medication details (drug name, drug strength, requested quantity, requested day supply, directions, diagnosis/ICD-10) and certify information

    See Medication Information and Medication History sections on the form

    Clinical eligibility: Member is a premenopausal female AND has a diagnosis of HSDD (hypoactive sexual desire disorder)

    Answered via form clinical questions

    Contributing factors assessment: Document whether HSDD is related to co-existing medical/psychiatric conditions, relationship problems, or medication/drug effects

    If related, documentation should be provided

    Reauthorization / Continuation Criteria

    Reauthorization criteria

    Reauthorization requests are approved when documentation shows clinical benefit while on therapy

    Reauthorization: Documented improvement in sexual desire from baseline while on Vyleesi (Yes/No)

    Answered on the Reauthorization section of the form

    Ongoing documentation: Updated medication history and any supporting clinical documentation submitted; provider certification of accuracy

    Authorization does not guarantee payment; payment subject to member eligibility

    Step Therapy and Behavioral Therapy Requirement

    RequirementForm question / documentationCoverage implication
    Is the member a candidate for behavioral therapy for HSDD? (Yes/No)
    Is the member currently enrolled in behavioral therapy for HSDD? (Yes/No)
    Has the member experienced therapeutic failure in behavioral therapy for HSDD? (Yes/No)
    Policy Summary
    PayerHighmark West Virginia
    PolicyVyleesi (bremelanotide) prior authorization form coverage criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit completed form with member and provider information, medication details, clinical answers about HSDD and behavioral therapy, and supporting documentation to request authorization.
    SourceLink
    On This Page
    Coverage Criteria and Form RequirementsRequested Diagnosis and CodesProvider Actions, Submission, and Prior AuthorizationBackgroundDefinitionsInitial Therapy RequirementsReauthorization / Continuation CriteriaStep Therapy and Behavioral Therapy Requirement
    Documentation Required

    Behavioral Therapy Assessment

    Assess and document the member's behavioral therapy status for HSDD. Indicate whether the member is a candidate for behavioral therapy, whether they are currently enrolled, and whether they have had therapeutic failure with behavioral therapy.

    • Was the member a candidate for behavioral therapy for HSDD? (Yes/No)
    • Is the member currently enrolled in behavioral therapy for HSDD? (Yes/No)
    • Has the member experienced therapeutic failure with behavioral therapy for HSDD? (Yes/No)
    Documentation Required

    Required Documentation and Submission

    Submit the completed form with all required member and provider information, medication details, clinical responses, signature, and supporting documentation to the specified fax or mailing address. Follow the instructions for completing and submitting the form.

    • Submit a separate form for each medication.
    • Fax the completed form and all clinical documentation to 1-866-240-8123.
    • Or mail the form to: 120 Fifth Avenue, SPECARE, Pittsburgh, PA 15222.
    • Provide physician address (required for physician notification) and ensure legible printing in blue or black ink.
    • The prescribing physician (PCP or Specialist) should, in most cases, complete the form.
    Denial Risk

    Provider Actions — Payment and Eligibility

    Payment is subject to member eligibility. An authorization, if granted, does not guarantee payment; final payment is determined at claim adjudication based on eligibility, benefits, and any applicable medical necessity review.

    • The submitting provider certifies the information is true, accurate, and complete and that the requested services are medically indicated and necessary.
    • Authorization does not guarantee payment; eligibility and benefits at the time of service will determine payment.
    Behavioral therapy requirement: Member is a candidate for behavioral therapy OR currently enrolled in behavioral therapy OR has experienced therapeutic failure in behavioral therapy

    Behavioral therapy status is queried on the form and supports need for pharmacotherapy

    Medication history: Provide prior medications tried and failed (free-text medication history)

    Medication History section required; provider must certify accuracy